Taiwan FDA registration 428061c1c0c491fd171b4b347b251f5e
Hemochron Jr. Prothrombin Time Test
TW: 漢莫克凝血酶原時間試驗
Taiwan·Risk Class 2·MD·Accriva Diagnostics Inc.·Registered Aug 07, 2013 – Aug 07, 2028ActiveRegistration details
- Analysis ID
- 428061c1c0c491fd171b4b347b251f5e
- License Form
- Ministry of Health Medical Device Import No. 025259
- Customs Code
- DHA05602525905
Company information
- Manufacturer
- Accriva Diagnostics Inc.
- Manufacturer Country
- United States
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- This product can be used with the applicable HEMOCHRON Jr. series analyzer to quantitatively determine the clotting time in whole blood.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B7750 Coagulation proto-temporal test
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 07, 2013
- Expiry Date
- Aug 07, 2028
About this record
Access comprehensive regulatory information for Hemochron Jr. Prothrombin Time Test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 428061c1c0c491fd171b4b347b251f5e and manufactured by Accriva Diagnostics Inc.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices